Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer denies purposely mutating COVID-19 virus

January 30, 2023
Medical Communications

Big Pharma company Pfizer has publicly denied allegations that it is deliberately mutating the COVID-19 virus in order to develop …

News

FDA suggests individual risk assessments for blood donations to secure US blood supply

January 30, 2023
Medical Communications

The FDA has announced that it is suggesting a change from the time-based deferrals for blood donation to an individual …

News

Researchers develop test to predict Alzheimer’s disease years before diagnosis

January 30, 2023
Medical Communications

Researchers at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have developed a blood test which can potentially …

News

Chiesi Farmaceutici hires new CEO after $1.48bn Amryst acquisition

January 30, 2023
Business Services

Chiesi Farmaceutici, a family-owned Italian pharmaceutical company, has appointed Giuseppe Accogli as group CEO. This comes after 2020’s $1.48bn acquisition …

News

FDA refuses to regulate CBD, calling on Congress to take charge

January 27, 2023
Medical Communications

The FDA is calling on the US Congress to work with them on a new regulatory pathway for cannabidiol (CBD). …

News

FDA pulls approval of COVID-19 antibody treatment due to inefficacy against variants

January 27, 2023
Medical Communications

The FDA has revoked its approval of AstraZeneca’s Evusheld due to the fact that it is not effective against more …

News

Ipsen reports CHMP negative review for use of palovarotene in EU

January 27, 2023
Research and Development

Ipsen, a biopharmaceutical company focused on medicines in oncology, rare diseases and neuroscience, have been denied marketing authorisation by the …

News

IsoChemiX develop molecules to speed up R&D process

January 27, 2023
Research and Development

UK-based pharmaceutical drug discovery company IsoChemiX is developing molecules which will have the ability to cut both the time and …

News

AI finds liver cancer drug candidate in only 30 days

January 26, 2023
Research and Development

With most drug discovery and development processes taking years, if not decades, a team of scientists have broken records with …

News

Merck’s London research hub to begin construction in April 2023

January 26, 2023
Business Services

Merck has been planning a $1.3bn, 220,000 square foot research hub in London for six years but will finally begin …

News

iNtRON confirms efficacy of ‘Inhalation Anthrax’-fighting drug

January 26, 2023
Medical Communications

iNtRON, a bio-new drug developing venture company, has announced the completion of an efficacy evaluation study of BAL200. It has …

News

Cell BioEngines announces exclusive licencing agreement for cancer cure

January 26, 2023
Medical Communications

US-based cell and gene therapy company Cell BioEngines has announced its exclusive licencing agreement with Icahn School of Medicine at …

News

t.bio chooses Automata as partner for automating a key aspect of its production of iPSC derived human cells

January 26, 2023
Business Services

26th January 2023, London UK – Automata, a leading robotics and automation company powering life sciences labs, today announced it …

News
Press release

Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease

January 26, 2023
Business Services

26 January 2023 Galway, Ireland – Orbsen Therapeutics Limited (“Orbsen”), a global leader in stromal cell immunotherapies, today announces encouraging …

News
Press release

First CAR T-cell therapy recommended for routine use on the NHS in England

January 26, 2023
Business Services

26th JANUARY 2023, LONDON, UK – Gilead Sciences Ltd. and Kite, a Gilead company, today announced that the National Institute …

News
Press release

Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases

January 26, 2023
Business Services

Paris, France and Eastleigh, UK – 26 January 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in …

News
Press release

Brits Living with Diabetes Feel Stigma and Bias Impact Their Ability to Manage Their Condition

January 26, 2023
Business Services

MAIDENHEAD, BERKSHIRE – TUESDAY 24 JANUARY 2023 – With diabetes prevalence expected to reach almost 5.5 million across the UK …

News
Press release

US Center for Disease Control (CDC) and two major medical journals cite the importance of decolonization in preventing surgical site infections

January 25, 2023
Business Services

Brighton, United Kingdom – 25 January 2023 – Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on …

News
Press release

Vertex and CRISPR Therapeutics Announce EMA Marketing Authorization Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa

January 25, 2023
Business Services

LONDON, UK and ZUG, Switzerland, January 25, 2023 – Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that …

News
Press release

STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML at the AACR Acute Myeloid Leukemia and Myelodysplastic Syndrome Conference

January 25, 2023
Business Services

25 January 2023, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule …

News
Press release
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026